Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Routine HIV Testing Will Help Destigmatize Disease

By LabMedica International staff writers
Posted on 07 Oct 2009
A third of human immunodeficiency virus (HIV)-related deaths could be avoided if testing for the disease was more widespread and more socially acceptable. More...
The introduction of universal testing is intended to destigmatize the process.

Guidelines for HIV testing called for tests to be offered to everyone accessing sexual health services, antenatal and abortion services, as well as drug dependency programs, and healthcare services for those diagnosed with tuberculosis. They should be routinely offered to anyone presenting with other clinical indicators for HIV infection, or with an identified risk factor for HIV whenever they access healthcare services.

Any doctor, nurse, midwife, or trained healthcare worker will be able to carry out HIV tests and help reduce late diagnoses of the virus. Treatment for people who discover they are HIV positive a long time after they have contracted the disease can be more difficult and while infected, they may have passed on the disease unknowingly.

The concise guidelines, which advocated normalization of HIV testing, were published on September 30, 2009 in Clinical Medicine the journal of the Royal College of Physicians (London, UK). The guidance was prepared on behalf of the HIV Testing Guidelines Writing Committee, and is a summary of the recommendations from the UK national guidelines for HIV testing 2008 produced by the British HIV Association.

The publication of these guidelines will be supported by a new HIV testing resource pack for clinicians produced by the Medical Foundation for AIDS and Sexual Health (MedFASH; London; UK), which will be launched at the British HIV Association Autumn conference 2009, on the 8th October, in London (UK).

Related Links:

Royal College of Physicians
British HIV Association
Medical Foundation for AIDS and Sexual Health



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.